Visual-field deficits associated with proton beam irradiation for parapapillary choroidal melanoma

Susanna Soon Chun Park, S. M. Walsh, E. S. Gragoudas

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: A large series of patients treated with proton irradiation for parapapillary choroidal melanoma were reviewed retrospectively to determine the frequency of radiation papillopathy and visual-field loss after treatment. Methods: Among 249 patients treated with proton irradiation for parapapillary choroidal melanoma, the authors identified 59 patients who had visual-field testing performed before treatment and at least 18 months after treatment. The visual fields, color fundus photographs, and charts were reviewed to determine the prevalence of radiation papillopathy and visual- field loss after treatment. Results: Nineteen of the 59 patients reviewed (31%) received a clinical diagnosis of radiation papillopathy. Progressive visual-field loss, defined as enlargement of absolute scotoma of less than or equal to 30° as compared with the pretreatment visual field, was noted in 67% of patients with radiation papillopathy and 73% of patients without papillopathy. In both groups, visual-field loss correlated with the area of the retina predicted to be exposed to irradiation in the majority of patients. Conclusions: Progressive visual-field loss is common after proton irradiation for parapapillary choroidal melanoma. However, the scotoma usually correlates with the area of the retina exposed to irradiation. The development of radiation papillopathy does not appear to be associated with additional visual-field defects in most cases.

Original languageEnglish (US)
Pages (from-to)110-116
Number of pages7
JournalOphthalmology
Volume103
Issue number1
StatePublished - 1996
Externally publishedYes

Fingerprint

Visual Fields
Protons
Melanoma
Radiation
Scotoma
Retina
Therapeutics
Color

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Visual-field deficits associated with proton beam irradiation for parapapillary choroidal melanoma. / Park, Susanna Soon Chun; Walsh, S. M.; Gragoudas, E. S.

In: Ophthalmology, Vol. 103, No. 1, 1996, p. 110-116.

Research output: Contribution to journalArticle

@article{a6935c1137b74a91b706c332e1cabd15,
title = "Visual-field deficits associated with proton beam irradiation for parapapillary choroidal melanoma",
abstract = "Purpose: A large series of patients treated with proton irradiation for parapapillary choroidal melanoma were reviewed retrospectively to determine the frequency of radiation papillopathy and visual-field loss after treatment. Methods: Among 249 patients treated with proton irradiation for parapapillary choroidal melanoma, the authors identified 59 patients who had visual-field testing performed before treatment and at least 18 months after treatment. The visual fields, color fundus photographs, and charts were reviewed to determine the prevalence of radiation papillopathy and visual- field loss after treatment. Results: Nineteen of the 59 patients reviewed (31{\%}) received a clinical diagnosis of radiation papillopathy. Progressive visual-field loss, defined as enlargement of absolute scotoma of less than or equal to 30° as compared with the pretreatment visual field, was noted in 67{\%} of patients with radiation papillopathy and 73{\%} of patients without papillopathy. In both groups, visual-field loss correlated with the area of the retina predicted to be exposed to irradiation in the majority of patients. Conclusions: Progressive visual-field loss is common after proton irradiation for parapapillary choroidal melanoma. However, the scotoma usually correlates with the area of the retina exposed to irradiation. The development of radiation papillopathy does not appear to be associated with additional visual-field defects in most cases.",
author = "Park, {Susanna Soon Chun} and Walsh, {S. M.} and Gragoudas, {E. S.}",
year = "1996",
language = "English (US)",
volume = "103",
pages = "110--116",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Visual-field deficits associated with proton beam irradiation for parapapillary choroidal melanoma

AU - Park, Susanna Soon Chun

AU - Walsh, S. M.

AU - Gragoudas, E. S.

PY - 1996

Y1 - 1996

N2 - Purpose: A large series of patients treated with proton irradiation for parapapillary choroidal melanoma were reviewed retrospectively to determine the frequency of radiation papillopathy and visual-field loss after treatment. Methods: Among 249 patients treated with proton irradiation for parapapillary choroidal melanoma, the authors identified 59 patients who had visual-field testing performed before treatment and at least 18 months after treatment. The visual fields, color fundus photographs, and charts were reviewed to determine the prevalence of radiation papillopathy and visual- field loss after treatment. Results: Nineteen of the 59 patients reviewed (31%) received a clinical diagnosis of radiation papillopathy. Progressive visual-field loss, defined as enlargement of absolute scotoma of less than or equal to 30° as compared with the pretreatment visual field, was noted in 67% of patients with radiation papillopathy and 73% of patients without papillopathy. In both groups, visual-field loss correlated with the area of the retina predicted to be exposed to irradiation in the majority of patients. Conclusions: Progressive visual-field loss is common after proton irradiation for parapapillary choroidal melanoma. However, the scotoma usually correlates with the area of the retina exposed to irradiation. The development of radiation papillopathy does not appear to be associated with additional visual-field defects in most cases.

AB - Purpose: A large series of patients treated with proton irradiation for parapapillary choroidal melanoma were reviewed retrospectively to determine the frequency of radiation papillopathy and visual-field loss after treatment. Methods: Among 249 patients treated with proton irradiation for parapapillary choroidal melanoma, the authors identified 59 patients who had visual-field testing performed before treatment and at least 18 months after treatment. The visual fields, color fundus photographs, and charts were reviewed to determine the prevalence of radiation papillopathy and visual- field loss after treatment. Results: Nineteen of the 59 patients reviewed (31%) received a clinical diagnosis of radiation papillopathy. Progressive visual-field loss, defined as enlargement of absolute scotoma of less than or equal to 30° as compared with the pretreatment visual field, was noted in 67% of patients with radiation papillopathy and 73% of patients without papillopathy. In both groups, visual-field loss correlated with the area of the retina predicted to be exposed to irradiation in the majority of patients. Conclusions: Progressive visual-field loss is common after proton irradiation for parapapillary choroidal melanoma. However, the scotoma usually correlates with the area of the retina exposed to irradiation. The development of radiation papillopathy does not appear to be associated with additional visual-field defects in most cases.

UR - http://www.scopus.com/inward/record.url?scp=0030022684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030022684&partnerID=8YFLogxK

M3 - Article

C2 - 8628541

AN - SCOPUS:0030022684

VL - 103

SP - 110

EP - 116

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 1

ER -